In The News Posted July 9, 2019 Share Posted July 9, 2019 CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., announced today the opening of its Eisai Center for Genetics Guided Dementia Discovery ("G2D2"), a new exploratory research facility located in Cambridge, Mass. Integrating cutting-edge... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.